L-Proline can be synthesized in mammalian cells from either L-ornithine or L-glutamic acid. The presumed mechanisms of proline formation are illustrated in Fig. 1 . The enzymes that catalyze the conversion of ornithine to pyrroline-5-carboxylic acid (ornithine aminotransferase, L-ornithine:2-oxo-acid aminotransferase, EC 2.6.1.13) and the subsequent reduction of pyrroline-5-carboxylic acid to proline [pyrroline-5-carboxylate reductase, L-proline:NAD(P)+ 5-oxidoreductase, EC 1.5.1 .2] have been characterized and extensively studied (1) . Results from radioisotopic tracer studies in intact animals (2) (3) (4) and nutritional studies in cultured cells (unpublished results) are consistent with the pathway leading from glutamic acid to pyrroline-5-carboxylic acid (P5C) shown in Fig. 1 . However, direct formation of P5C by this enzyme or enzyme complex, which we have designated P5C synthase, has not been demonstrated in mammalian cells.
By providing appropriate concentrations of cofactors, we have developed a method for measuring the specific activity of P5C synthase in cell-free homogenates of mammalian cells. The determination of P5C formation from glutamic acid is made possible by specifically blocking further metabolism of P5C. We have verified that the assay provides a valid measure of the P5C synthase pathway by comparing two Chinese hamster ovary cell lines that differ from each other only in the presence or absence of the pathway from glutamic acid to P5C.
MATERIALS AND METHODS

Materials. L-[U-'4C]Glutamic acid and L-[U-'4C]proline
were obtained from New England Nuclear. AG 50W cationexchange resins were from Bio-Rad. Disposal polypropylene
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 Kao and Puck (6) . The line designated C9 was cloned from CHO-K1 cells by a dilution technique in microtiter plates in a medium supplemented with 0.1 mM proline. Like the parent CHO-K1 cells, the C9 line is proline auxotrophic, requiring proline supplementation of the medium for survival. The R25 line was selected by plating CHO-K1 cells in medium containing 2 mM glutamine, but lacking proline or ornithine, thus favoring cells that had acquired the capacity to form proline from glutamate. Under these selective conditions, rare colonies 6f growing cells formed. One colony was isolated and designated R25. For subsequent studies, the cells were maintained in monolayer by repeated subculturing in Eagle's minimal essential medium supplemented with 10% (vol/vol) fetal bovine serum and, for C9 cells, with Eagle's nonessential amino acids.
Preparation of Cell Homogenates. Cell suspensions were prepared by controlled incubation of monolayers in 0.25% trypsin, and the cells were plated in the above media in 100-mm petri dishes (1.2-2.5 X 106 cells per dish). After incubation for 16-48 hr, the medium was removed and the cells were gently scraped into ice-cold Dulbecco's phosphate-buffered saline with a rubber spatula. The cells were centrifuged for 10 min at 1000 X g, resuspended in cold phosphate-buffered saline, recentrifuged, and finally suspended in a small volume of 0.1 M potassium phosphate buffer (pH 7.4). Cells were disrupted by freezing and thawing twice or by sonicating for 40 sec in a Heat Systems Sonifier equipped with a Cup Horn. Protein concentration of cell homogenates was determined by the method of Lowry et al. (7), with bovine insulin as a standard.
Characterization of Cellular Metabolic Pathways. Specific activities of P5C reductase, ornithine aminotransferase, P5C dehydrogenase, and proline oxidase in C9 and R25 homogenates were measured with radioisotopic assays as described (8) (9) (10) (11) . The rate of conversion of glutamic acid to proline in intact cells was determined by a described method (12 P5C Formation from Glutamic Acid in Cell Homogenates (P5C Synthase Activity). The reaction mixture was identical to that described for measuring proline formation, except that it also contained 0.125 mg of OAB and 50 .mol of L-proline.
After incubation at 37°C, the reaction was stopped by adding 0.05 ml of 6 M HC1 containing 30 mg of OAB per ml. The samples were incubated for an additional 5 min at 370C to promote optimal P5C-GOAB binding and centrifuged for 5 min at 2000 X g. The supernatants were placed on 1-ml bed volume columns of AG50W (100-200 mesh, 8% crosslinked, hydrogen form). After elution with 16 ml of 2 M HC1, the OAB-P5C condensation product was eluted as a sharp peak with 2 M NaOH and quantified by liquid scintillation spectrometry.
RESULTS
The R25 cells were chosen for the initial studies because they had the capacity for proline formation from glutamic acid in intact cells and thus were expected to have P5C synthase activity. By using cell-free homogenates of R25 cells, we first looked for the formation of proline from glutamic acid. The R25 homogenates catalyzed proline formation at the rate of 10.03 nmol/hr per mg of protein ( Fig. 2A) . The identity of product proline was confirmed by its comigration with pure L-[14C]proline on 3-ml columns of AG50W (200-400 mesh) cation-exchange resin (Fig. 2B) . Under these conditions, proline was separated from substrate glutamic acid as well as from a-ketoglutarate, glutamine, and P5C.
Because proline formation from glutamate presumably involved P5C as an intermediate (see Fig. 1 ), we next looked for P5C formation by terminating the reaction with 6 M HCO containing 30 mg of OAB per ml. Al-Pyrroline compounds react specifically with OAB (13) . Previous studies by Phang et al. (11) had also shown that the dihydroquinazolinium product of OAB and P5C bound to AG50W under acid conditions. By use of a 1-ml bed volume column of AG50W (100-200 mesh), labeled glutamic acid, a-ketoglutarate, glutamine, and proline could be eluted with 2 M HC1 and the condensation product of OAB and [14C]P5C could subsequently be eluted as a sharp peak with 2 M NaOH (Fig. 3A) . The (2.7 ,Ci/nmol), 1 .25 nmol of ATP, 6 .25 nmol of MgCl2, 3 .626 nmol of creatine phosphate, 2 units of creatine phosphokinase, 0.1 nmol of NADPH, 2.5 nmol of DL-isocitrate, 0.9 unit of isocitrate dehydrogenase, and 0.25 nmol of 2-mercaptoethanol in 0.25 ml of 0.1 M potassium phosphate buffer (pH 7.4). After incubation for 60 min at 37°C, the reaction was terminated with 0.05 ml of 6 M HCl and the mixture was centrifuged. The supernatant was placed on a 3-ml bed volume column of AG50W (200-400 mesh) and eluted with 1 When homogenates of R25 cells were incubated with L-[14C]glutamic acid as described above and treated with OAB in 6 M HCl, only 1.73 nmol of P5C product per hr per mg of protein was recovered. Because proline was formed at a much higher rate (i.e., 10.03 nmol/hr per mg of protein), we reasoned that most of the P5C formed from glutamic acid must have been reduced to proline. Therefore, we attempted to block the further metabolism of P5C (Table 1) . Addition of OAB (0.5 mg/ml) during the incubation, which forms a complex with P5C, increased P5C formation to 4.20 nmol/hr per mg of protein and simultaneously decreased proline formation by 19%. Presumably, OAB complexed with P5C, making it un- Enzyme specific activities in homogenates of C9 and R25 cells were determined with sensitive radioisotopic assays as described (8) (9) (10) (11) [14C]glutamic acid. As shown in Fig. 4 , the C9 cell line was unable to incorporate proline derived from glutamate, whereas the R25 line readily incorporated glutamate-derived proline. Both lines incorporated [14C]glutamic acid itself into protein, thereby excluding a transport defect in the C9 cells. We concluded that the C9 line cannot synthesize P5C from either ornithine or glutamic acid, although it can convert P5C to proline. The R25 line has specifically acquired the capacity to form P5C from glutamic acid. There are no other known differences between the two cell types.
In agreement with the studies in intact cells, P5C synthase activity was undetectable in cell-free homogenates of C9 and present at 5.97 nmol/hr per mg of protein in homogenates of R25 cells. Thus, P5C synthase activity measured with our assay correlates with the capacity for P5C formation from glutamic acid in intact cells.
Further characterization of P5C synthase activity in R25 cells showed that P5C formation increased linearly for up to 120 min of incubation after an initial lag period of approximately 10 min (Fig. 5A) . The lag could be reduced to less than 5 min by preincubating the cell homogenate for 60 min at 37°C (data not shown). Product formation also increased linearly as the amount of added cell homogenate protein was increased from 100 to 400,glg per assay (Fig. SB) .
The reaction required inorganic phosphate and was maximal at a phosphate concentration of 0.1 M. There was no activity with either Tris-HCI or Hepes buffer in the absence of phosphate. NADPH, ATP, and their respective regenerating systems were required for optimal activity (Table 3 ). The formation of product P5C increased linearly as the concentration of glutamic acid was increased from 0.03 to 100 mM (Fig. 6) . Although most of the above experimental data were derived with cells disrupted by repeat freezing and thawing, we determined the activity at different glutamic acid concentrations with freeze-thawed and sonicated preparations and found that P5C formation increased linearly as glutamic acid concentration increased with either procedure. Thus, it is unlikely that the lack (Fig. 1) . The reduction of P5C to proline by P5C reductase has subsequently been characterized in mammalian cells (16) Strecker (18) (Fig. 7) . The labile 'y-glutamyl phosphate intermediate would be expected to require tightly linked phosphorylation and reduction activities, which might explain why the activity of the pathway has previously been so elusive. The success of our method most probably depends upon the concurrent provision of regenerating systems for both ATP and NADPH. Preliminary work with other cell types (data not shown) indicates that the pathway can be measured in other cultured cells.
The radioisotopic assay is specific and sensitive enough for measurement of P5C synthase activity in small quantities of tissue. It should enable us to characterize the activity and regulation of this previously unstudied enzyme in differentiated mammalian tissues.
